name

hye

sex

age

66 岁

hospital number

17012261

height

155 cm

weight

48 kg

BSA

1.4 m2

APACHEⅡ

11 分

Infection source

date

2017/4/30 年/月/日

Sequential Organ Failure Assessment

分

Fluid resuscitation

age>=60

septic shock

mechanical ventilation

Early fluid resuscitation

age<60

Pregnant woman

advanced malignant tumor

Pulmonary interstitial fibrosis

Serious arrhythmia

Small Tidal Volume Ventilation

Liver failure

Refuse to participate

Heart disease

泰能、万古霉素

vasoactive agent

10 min

10 min

20 min

Temperature

36.7 ℃

Heart Rate

95 次/分

Breath

22 次/分

Systolic pressure (SP)

141 mmHg

Diastolic pressure

67 mmHg

mean arterial pressure

88 mmHg

Pcv-aCO2

3 mmHg

DO2

580.27

VO2

144.88

Ca-vO2

20.65

pH value

7.38

PaO2

116 mmHg

PaCO2

37 mmHg

BE

-3.5 mmol/L(±2.3mmol/L)

SaO2

99.70 %

Blood lactic acid concentration, LAC

1.4 mmol/L

Oxygenation index (PaO2/FiO2)

290.00 mmHg

pH value

7.36

PcvO2

43 mmHg

PcvCO2

40 mmHg

BE

-3.1 mmol/L

ScvO2

74.70 %

Volume of input

600 ml

Volume of output

150 ml

Volume of urine

150 ml

ultrafiltration volume

0 ml

norepinephrine

Norepinephrine Dosage

0.0023 μg/Kg/min

dopamine

Dopamine Dosage

μg/Kg/min

Dobutamine

Dobutamine Dosage

μg/Kg/min

CVP

7 mmHg

cardiac output

7.09 L/min

cardiac index

5.06 L/min/m2

stroke volume

85 ml

Stroke Index

60 ml/m2

ITBVI

1073 ml/m2

GEDVI

859 ml/m2

EVLWI

6 ml/kg

PVPI

0.9

SVRI

800 DSm2/cm5

CFI

5.7

GEF

23.00 %

SVV

7.00 %

PPV

5 %

dPmax

1514

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

the number of B line

2 条

LUS

4 分

B+ Zone

区

IVC(inspiratory phase)

20.7 mm

IVC(expiratory phase)

19.4 mm

respiratory variations of inferior vena cavae diameter

6.48 %

mm

mm

mm

mm

Temperature

37.3 ℃

Heart Rate

100 次/分

Breath

15 次/分

Systolic Pressure

99 mmHg

Diastolic Pressure

48 mmHg

Mean Arterial Pressure

66 mmHg

Pcv-aCO2

5 mmHg

DO2

783.77

VO2

168.21

Ca-vO2

21.56

PH value

7.39

PaO2

125 mmHg

PaCO2

35 mmHg

BE

-4 mmol/L

SaO2

99.80 %

Blood Lactic Acid Concentration

2.2 mmol/L

Oxygenation index (PaO2/FiO2)

312.50 mmHg

PH value

7.36

PcvO2

46 mmHg

PcvCO2

40 mmHg

BE

-3.4 mmol/L

ScvO2

78.30 %

Volume of input

1600 ml

Volume of output

1500 ml

Volume of urine

1500 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

1.56 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

7 mmHg

cardiac output

7.89 L/min

cardiac index

5.62 L/min/m2

stroke volume

73 ml

Stroke Index

52 ml/m2

ITBVI

938 ml/m2

GEDVI

751 ml/m2

EVLWI

7 ml/kg

PVPI

1.2

SVRI

982 DSm2/cm5

CFI

7.3

GEF

26.00 %

SVV

7.00 %

PPV

6 %

dPmax

1448

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

2 条

LUS

4 分

B+ Zone

区

IVC(inspiratory phase)

21.3 mm

IVC(expiratory phase)

19.5 mm

Respiratory variations of inferior vena cavae diameter

8.82 %

mm

mm

mm

mm

Temperature

38.6 ℃

Heart Rate

101 次/分

Breath

15 次/分

Systolic Pressure

133 mmHg

Diastolic Pressure

61 mmHg

Mean Arterial Pressure

92 mmHg

Pcv-aCO2

3 mmHg

DO2

519.42

VO2

115.30

Ca-vO2

17.02

PH value

7.38

PaO2

141 mmHg

PaCO2

34 mmHg

BE

-4.8 mmol/L

SaO2

99.90 %

Blood Lactic Acid Concentration

2.7 mmol/L

Oxygenation index (PaO2/FiO2)

352.50 mmHg

PH value

7.39

PcvO2

46 mmHg

PcvCO2

37 mmHg

BE

-2.5 mmol/L

ScvO2

77.60 %

Volume of input

3400 ml

Volume of output

1100 ml

Volume of urine

450 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

3.2 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

7 mmHg

cardiac output

6.89 L/min

cardiac index

4.07 L/min/m2

stroke volume

76 ml

Stroke Index

59 ml/m2

ITBVI

1035 ml/m2

GEDVI

829 ml/m2

EVLWI

7 ml/kg

PVPI

1

SVRI

1459 DSm2/cm5

CFI

4.8

GEF

21.00 %

SVV

8.00 %

PPV

5 %

dPmax

907

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

2 条

LUS

4 分

B+ Zone

区

IVC(inspiratory phase)

20.7 mm

IVC(expiratory phase)

19.8 mm

Respiratory variations of inferior vena cavae diameter

4.44 %

mm

mm

mm

mm

Temperature

35.7 ℃

Heart Rate

76 次/分

Breath

14 次/分

Systolic Pressure

111 mmHg

Diastolic Pressure

61 mmHg

Mean Arterial Pressure

84 mmHg

Pcv-aCO2

5.00 mmHg

DO2

611.49

VO2

211.24

Ca-vO2

32.87

PH value

7.49

PaO2

140 mmHg

PaCO2

34 mmHg

BE

1.6 mmol/L

SaO2

100.00 %

Blood Lactic Acid Concentration

1.4 mmol/L

Oxygenation index (PaO2/FiO2)

350.00 mmHg

PH value

7.47

PcvO2

33 mmHg

PcvCO2

39 mmHg

BE

3.4 mmol/L

ScvO2

65.30 %

Volume of input

7280 ml

Volume of output

4600 ml

Volume of urine

1200 ml

Ultrafiltration Volume

1300 ml

Norepinephrine Dosage

6 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

7 mmHg

cardiac output

6.41 L/min

cardiac index

4.57 L/min/m2

stroke volume

68 ml

Stroke Index

49 ml/m2

ITBVI

892 ml/m2

GEDVI

714 ml/m2

EVLWI

6 ml/kg

PVPI

1

SVRI

1262 DSm2/cm5

CFI

6.2

GEF

26.00 %

SVV

4.00 %

PPV

4 %

dPmax

886

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

2 条

LUS

4 分

B+ Zone

区

IVC(inspiratory phase)

20.3 mm

IVC(expiratory phase)

19.7 mm

Respiratory variations of inferior vena cavae diameter

3.0 %

mm

mm

mm

mm

Temperature

36.3 ℃

Heart Rate

79 次/分

Breath

12 次/分

Systolic Pressure

118 mmHg

Diastolic Pressure

72 mmHg

Mean Arterial Pressure

87 mmHg

Pcv-aCO2

3.00 mmHg

DO2

636.14

VO2

130.24

Ca-vO2

20.88

PH value

7.44

PaO2

119 mmHg

PaCO2

41 mmHg

BE

3.2 mmol/L

SaO2

98.80 %

Blood Lactic Acid Concentration

1.8 mmol/L

Oxygenation index (PaO2/FiO2)

297.50 mmHg

PH value

7.43

PcvO2

50 mmHg

PcvCO2

44 mmHg

BE

3.7 mmol/L

ScvO2

78.50 %

Volume of input

10252 ml

Volume of output

7545 ml

Volume of urine

1660 ml

Ultrafiltration Volume

2265 ml

Norepinephrine Dosage

6 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

7 mmHg

cardiac output

6.3 L/min

cardiac index

5.03 L/min/m2

stroke volume

78 ml

Stroke Index

56 ml/m2

ITBVI

966 ml/m2

GEDVI

772 ml/m2

EVLWI

6 ml/kg

PVPI

1

SVRI

2088 DSm2/cm5

CFI

6.4

GEF

27.00 %

SVV

6.00 %

PPV

8 %

dPmax

1251

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

2 条

LUS

4 分

B+ Zone

区

IVC(inspiratory phase)

20.2 mm

IVC(expiratory phase)

20 mm

Respiratory variations of inferior vena cavae diameter

1.00 %

mm

mm

mm

mm

Temperature

36.2 ℃

Heart Rate

79 次/分

Breath

15 次/分

Systolic Pressure

124 mmHg

Diastolic Pressure

68 mmHg

Mean Arterial Pressure

87 mmHg

Pcv-aCO2

3.00 mmHg

DO2

659.54

VO2

136.50

Ca-vO2

21.04

PH value

7.64

PaO2

78 mmHg

PaCO2

20 mmHg

BE

2.5 mmol/L

SaO2

94.00 %

Blood Lactic Acid Concentration

2.2 mmol/L

Oxygenation index (PaO2/FiO2)

195.00 mmHg

PH value

7.58

PcvO2

34 mmHg

PcvCO2

23 mmHg

BE

-0.2 mmol/L

ScvO2

74.50 %

Volume of input

13352 ml

Volume of output

9695 ml

Volume of urine

1210 ml

Ultrafiltration Volume

2265 ml

Norepinephrine Dosage

6 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

7 mmHg

cardiac output

6.53 L/min

cardiac index

3.72 L/min/m2

stroke volume

65 ml

Stroke Index

43 ml/m2

ITBVI

970 ml/m2

GEDVI

776 ml/m2

EVLWI

7 ml/kg

PVPI

1.2

SVRI

1529 DSm2/cm5

CFI

4.7

GEF

25.00 %

SVV

10.00 %

PPV

8 %

dPmax

1121

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

2 条

LUS

4 分

B+ Zone

区

IVC(expiratory phase)

20.3 mm

Respiratory variations of inferior vena cavae diameter

20.1 %

IVC(inspiratory phase)

0.99 mm

mm

mm

mm

mm

NT-proBNP

pg/ml

BNP

594 pg/ml

cTNI

0.099 ng/ml

Creatine kinase isoenzyme, CKMB

21.6 U/L

Creatinine

131 umol/L

Urea nitrogen

11.4 mmol/l

MDRD

35.233 ml/min/1.73m2

Date of examination

yyyy-mm-dd

WBC

4.2 X10*9/L

neutrophilic granulocyte percentage

91.8 %

Hb

g/L

CRP

76.5 mg/L

Procalcitonin, PCT

1.45 ng/ml

Date of test

Sequential Organ Failure Assessment

26 分

NT-proBNP

pg/ml

BNP

543 pg/ml

cTNI

0.076 ng/ml

Creatine kinase isoenzyme, CKMB

23.6 U/L

Creatinine

80 umol/L

Urea nitrogen

6.4 mmol/l

MDRD

62.246 ml/min/1.73m2

WBC

5.2 X10*9/L

neutrophilic granulocyte percentage

91 %

Hb

g/L

CRP

91.5 mg/L

Procalcitonin, PCT

0.927 ng/ml

Sequential Organ Failure Assessment

22 分

NT-proBNP

pg/ml

BNP

692 pg/ml

cTNI

0.074 ng/ml

Creatine kinase isoenzyme, CKMB

25.8 U/L

Creatinine

124 umol/L

Urea nitrogen

8.2 mmol/L

MDRD

37.538 ml/min/1.73m2

WBC

4.1 X10*9/L

neutrophilic granulocyte percentage

77.5 %

Hb

g/L

CRP

33.9 mg/L

Procalcitonin, PCT

0.771 ng/ml

Sequential Organ Failure Assessment

15 分

Transfusion of Red Cells

Transfusion of Red Cells

8.5 U

Plasma infusion

Plasma infusion

750 ml

platelet transfusion

platelet transfusion

10 U

APACHEⅡ

21 分

Complication

prognosis

28-day mortality

survival time(day)

天

death time

yyyy/mm/dd

diagnosis of death

length of stay

56 天

duration in ICU

25 天

duration of mechanical ventilation

25 小时

ICU expenses

元

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

72 小时